Related Experiment Video
Updated: Aug 5, 2026

10:28
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Extremely Rare Prostate Metastasis From Rectal Carcinoma Detected on ⁶⁸Ga-FAPI PET/CT
Parth Bambhroliya1, T Kishan Subudhi1, Srijani Mandal1
1Departments of Nuclear Medicine.
Clinical Nuclear Medicine
|July 29, 2026
Summary
Metastatic colorectal adenocarcinoma rarely spreads to the prostate. This case highlights a 52-year-old man with rectal cancer who developed prostate metastases, confirmed by biopsy and imaging.
Area of Science:
- Oncology
- Urology
- Medical Imaging
Background:
- Prostate metastases from colorectal adenocarcinoma are rare.
- They typically arise from local extension, not distant spread.
- This case presents a unique instance of distant prostate metastasis from rectal cancer.
Purpose of the Study:
- To report a rare case of prostate metastasis from rectal adenocarcinoma.
- To illustrate the diagnostic utility of ⁶⁸Ga-FAPI PET/CT in identifying such metastases.
- To discuss the clinical presentation and diagnostic challenges.
Main Methods:
- Case report of a 52-year-old male with a history of rectal adenocarcinoma.
- Clinical evaluation including assessment of lower urinary tract symptoms, serum creatinine, prostate-specific antigen (PSA), and cancer embryonic antigen (CEA).
- Diagnostic imaging with whole-body ⁶⁸Ga-FAPI PET/CT followed by prostate biopsy.
Main Results:
- The patient presented with lower urinary tract symptoms and elevated creatinine.
- Colonoscopy showed no local recurrence, but CEA levels were high.
- ⁶⁸Ga-FAPI PET/CT revealed diffuse prostate uptake, confirmed as metastatic adenocarcinoma on biopsy.
Conclusions:
- Metastatic involvement of the prostate by colorectal adenocarcinoma can occur as true distant spread.
- ⁶⁸Ga-FAPI PET/CT is a valuable tool for detecting prostate metastases from colorectal cancer.
- This case underscores the importance of considering unusual metastatic patterns in cancer patients.